HEXA rs121907999: Tay-Sachs Carrier Status
The genetic variant rs121907999 is a well-characterized four-base-pair insertion (commonly designated c.1278insTATC or c.1277_1278dupTATC) within the HEXA gene on chromosome 15. Inheriting one copy of this variant confers carrier status for classic infantile Tay-Sachs disease, an autosomal recessive lysosomal storage disorder. Because carriers typically possess sufficient functional enzyme activity from their normal allele, they do not experience symptoms themselves.
What each genotype means
Tay-Sachs carrier
Published clinical data show that individuals with one copy of this frameshift insertion are healthy carriers for autosomal recessive Tay-Sachs disease. Carriers typically produce sufficient hexosaminidase A enzyme from their functional allele to maintain normal health and will not develop the condition themselves. Because this status is significant for family planning, individuals planning to have children may discuss carrier screening and reproductive risk counseling with a healthcare provider or genetic counselor.
Carried by approximately 1 in 30 individuals of Ashkenazi Jewish descent and roughly 1 in 300 individuals in the general non-Jewish population, with localized founder effects reported in French-Canadian and Louisiana Cajun communities.
Tay-Sachs disease risk
Research identifies this homozygous frameshift genotype (c.1274_1277dup / c.1278insTATC) as a cause of absent or severely deficient hexosaminidase A enzyme activity. In published clinical literature, individuals with two non-functional copies of HEXA are affected by infantile-onset Tay-Sachs disease, characterized by progressive neurodegeneration. Because this finding carries substantial clinical implications, formal diagnostic confirmation and evaluation with a qualified medical genetics specialist are indicated.
Extremely rare in the global general population (less than 1 in 100,000), occurring at a higher frequency of approximately 1 in 3,600 to 1 in 4,000 live births in unscreened Ashkenazi Jewish populations prior to widespread carrier screening programs.
Variant Identity and Location
The variant rs121907999 represents a small insertion located in exon 11 of the HEXA gene on chromosome 15q23. In molecular genetics literature and carrier screening panels, it is frequently described as c.1278insTATC, c.1274_1277dupTATC, or p.Tyr427Ilefs*5. This alteration introduces an extra four nucleotides (TATC) into the coding sequence of the transcript. Because the insertion length is not a multiple of three, it disrupts the normal triplet reading frame during translation, resulting in a premature termination codon. This frameshift prevents the creation of a functional full-length protein subunit, classifying it biochemically as a null allele.
Biological Role of the HEXA Gene
The HEXA gene provides the genetic blueprint for the alpha subunit of the heterodimeric enzyme beta-hexosaminidase A (Hex A). Functioning within cellular lysosomes alongside a beta subunit and a GM2 activator protein, Hex A catalyzes the breakdown of GM2 gangliosides into GM3 gangliosides. GM2 gangliosides are critical glycosphingolipids found abundantly in neuronal cell membranes. When functional Hex A enzyme levels are critically depleted, unprocessed GM2 gangliosides progressively accumulate inside neuronal lysosomes. Over time, this substrate accumulation leads to cell swelling, neurodegeneration, and severe central nervous system impairment.
Clinical Significance and Disease Association
Decades of clinical literature establish rs121907999 as a classic pathogenic variant associated with acute infantile Tay-Sachs disease. Tay-Sachs is an autosomal recessive condition, meaning disease manifests only when an individual carries two pathogenic HEXA variants—one inherited from each biological parent. Infantile-onset Tay-Sachs typically presents between 3 and 6 months of age with developmental arrest, rapid loss of motor milestones, visual impairment, seizures, and characteristic macular 'cherry-red spots.' Heterozygous carriers possessing one altered allele and one standard allele maintain adequate Hex A activity (typically around 50% of reference levels) and remain entirely asymptomatic.
Population Frequency and Carrier Rates
While rs121907999 is exceptionally rare across the global population, it demonstrates significant founder effects in specific demographic groups. In individuals of Ashkenazi Jewish ancestry, this specific four-base-pair insertion represents the most prevalent pathogenic HEXA mutation, contributing to an overall Tay-Sachs carrier frequency of approximately 1 in 30. Elevated frequencies of HEXA pathogenic variants have also historically been documented in French-Canadian communities of eastern Quebec, Cajun populations in Louisiana, and Old Order Amish demes. By contrast, in the general non-Jewish population, the combined carrier frequency for any pathogenic HEXA variant is estimated between 1 in 250 and 1 in 300.
Navigating Results and Next Steps
Identifying an rs121907999 variant on an informational genetic test indicates carrier status rather than a personal medical diagnosis. Carriers do not require therapeutic intervention, nor are they at elevated personal risk for neurological decline. The primary utility of this finding relates to family planning and reproductive genetics. If both biological parents carry a pathogenic HEXA variant, there is a 25% (1 in 4) probability in each pregnancy of having an affected child. Individuals who identify as carriers are encouraged to discuss confirmatory diagnostic testing and certified genetic counseling with a qualified healthcare professional.
How common is this variant?
The rs121907999 insertion is rare globally, but accounts for a carrier frequency of approximately 1 in 30 individuals in Ashkenazi Jewish populations due to a historical founder effect, compared to approximately 1 in 250 to 1 in 300 across general non-Jewish ancestries.
Frequently asked questions
Does having the rs121907999 insertion mean I will develop Tay-Sachs disease?
No. Tay-Sachs disease is an autosomal recessive condition requiring two altered copies of the gene to manifest clinically. Carrying a single copy of rs121907999 makes you an asymptomatic carrier with sufficient functional enzyme activity to maintain health.
How does the rs121907999 variant affect the HEXA enzyme?
The variant adds four nucleotides into exon 11 of the HEXA gene, disrupting the reading frame and creating a premature stop signal. This completely prevents the synthesis of functional alpha subunits for the beta-hexosaminidase A enzyme from that specific allele.
What are the reproductive risks if I carry rs121907999?
If your reproductive partner does not carry a pathogenic HEXA variant, your children cannot develop Tay-Sachs disease, though each child has a 50% chance of inheriting carrier status. If both partners carry a pathogenic HEXA mutation, each pregnancy carries a 25% risk of being affected by Tay-Sachs disease.
Are consumer direct-to-consumer tests sufficient to confirm my carrier status?
While direct-to-consumer genotyping arrays can screen for targeted founder mutations like rs121907999, they often do not sequence the entire HEXA gene. Clinical-grade diagnostic sequencing or biochemical hexosaminidase enzyme assays ordered through a physician are recommended to fully evaluate carrier status.
Sources & further reading
Educational information only, last refreshed 9/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121907999?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in HEXA
Canonical splice junction variant (c.1073+1G>A) causing Tay-Sachs disease.
Pathogenic splice donor variant (c.1421+1G>C) in HEXA underlying carrier status for autosomal recessive infantile Tay-Sachs disease.
Pathogenic splice-junction variant (c.1073+1G>A / IVS9+1G>A) causing Tay-Sachs disease when in compound heterozygosity or homozygosity.
This HEXA variant is associated with Tay-Sachs disease, particularly late-onset forms.
Pathogenic splice junction mutation (c.1421+1G>C) in HEXA leading to Tay-Sachs disease.
Pathogenic HEXA splice donor site mutation (c.1073+1G>A) causing Tay-Sachs disease, common in carrier screening panels for Ashkenazi Jewish and French Canadian ancestry.